Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/18/2025 | CALL | $5.00 | 10 | +10 | |
| 08/15/2025 | CALL | $2.50 | 15 | 0 | |
| 08/15/2025 | CALL | $5.00 | 1 | 0 | |
| 08/15/2025 | CALL | $7.50 | 2 | 0 | |
| 08/15/2025 | PUT | $2.50 | 0 | 0 | |
| 08/15/2025 | PUT | $5.00 | 0 | 0 | |
| 02/20/2026 | CALL | $2.50 | 0 | 0 | |
| 02/20/2026 | CALL | $5.00 | 0 | 0 | |
| 02/20/2026 | CALL | $7.50 | 0 | 0 | |
| 02/20/2026 | PUT | $2.50 | 0 | 0 | |
| 02/20/2026 | PUT | $5.00 | 0 | 0 | |
| 02/20/2026 | PUT | $7.50 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - Pipeline Innovations Expected to Add $1.8 Billion in Bronchiectasis Market Sales
05/23 04:49 am
GlobeNewswire Inc.
Read morePhage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight
01/23 02:00 pm
GlobeNewswire Inc.
Read moreBronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight
01/21 02:00 pm
GlobeNewswire Inc.
Read moreGroundbreaking Insights Unveiled in Non-Cystic Fibrosis Bronchiectasis Pipeline Report
11/28 11:57 am
GlobeNewswire Inc.
Read moreY-mAbs Therapeutics, Inc. (YMAB) Reports Q3 Loss, Lags Revenue Estimates
11/13 06:25 pm
Zacks Investment Research
Read moreArmata Pharma (ARMP) Stock Surges 130% in a Month: Here's Why
08/22 10:18 am
Zacks Investment Research
Read moreArmata Pharmaceuticals, Inc. (ARMP) Now Trades Above Golden Cross: Time to Buy?
08/17 09:55 am
Zacks Investment Research
Read moreCardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
08/09 06:05 pm
Zacks Investment Research
Read moreLigand Pharmaceuticals (LGND) Q2 Earnings Beat Estimates
08/08 05:40 pm
Zacks Investment Research
Read moreMorphic Holding, Inc. (MORF) Reports Q2 Loss, Lags Revenue Estimates
08/03 08:55 am
Zacks Investment Research
Read moreVericel Corporation (VCEL) Reports Q2 Loss, Tops Revenue Estimates
08/02 09:05 am
Zacks Investment Research
Read moreDow Surges 150 Points; Domino's Pizza Earnings Top Expectations
07/24 10:45 am
Benzinga
Read moreArmata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
05/11 05:25 pm
Zacks Investment Research
Read moreInovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates
05/10 05:45 pm
Zacks Investment Research
Read moreCue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates
05/09 05:55 pm
Zacks Investment Research
Read moreArmata Pharmaceuticals, Inc. (ARMP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
12/08 10:55 am
Zacks Investment Research
Read moreAfter Plunging 35.3% in 4 Weeks, Here's Why the Trend Might Reverse for Armata Pharmaceuticals, Inc. (ARMP)
11/28 10:35 am
Zacks Investment Research
Read moreHere's Why Armata Pharmaceuticals, Inc. (ARMP) Looks Ripe for Bottom Fishing
11/15 10:55 am
Zacks Investment Research
Read moreArmata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates
11/09 07:45 pm
Zacks Investment Research
Read moreUS Stocks Turn Lower; Nasdaq Drops Over 100 Points
09/15 12:04 pm
Benzinga
Read moreArmata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Tops Revenue Estimates
08/11 05:45 pm
Zacks Investment Research
Read moreTELA Bio, Inc. (TELA) Reports Q2 Loss, Tops Revenue Estimates
08/10 05:35 pm
Zacks Investment Research
Read moreAvidity Biosciences, Inc. (RNA) Reports Q2 Loss, Lags Revenue Estimates
08/09 07:05 pm
Zacks Investment Research
Read moreThis Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
06/28 04:23 am
Benzinga
Read moreWhy Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
06/27 12:26 pm
Benzinga
Read moreArmata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Tops Revenue Estimates
05/12 06:15 pm
Zacks Investment Research
Read moreTFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Misses Revenue Estimates
05/11 05:15 pm
Zacks Investment Research
Read moreMyovant Sciences (MYOV) Reports Q4 Loss, Misses Revenue Estimates
05/10 08:05 am
Zacks Investment Research
Read moreExecutives Buy Over $30M Of 3 Stocks
04/04 12:33 pm
Benzinga
Read moreWall Street Analysts See a 52% Upside in Armata Pharmaceuticals, Inc. (ARMP): Can the Stock Really Move This High?
03/22 10:00 am
Zacks Investment Research
Read more1 Healthcare Stock That Could Fly Higher After a Strong Q4
03/05 12:23 pm
The Motley Fool
Read moreThe Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
02/10 09:29 am
Benzinga
Read moreRecent Price Trend in Armata Pharmaceuticals, Inc. (ARMP) is Your Friend, Here's Why
01/06 09:50 am
Zacks Investment Research
Read moreHas Abiomed (ABMD) Outpaced Other Medical Stocks This Year?
12/30 10:40 am
Zacks Investment Research
Read moreWall Street Analysts Believe Armata Pharmaceuticals, Inc. (ARMP) Could Rally 47%: Here's is How to Trade
11/29 11:00 am
Zacks Investment Research
Read moreWhat Makes Armata Pharmaceuticals, Inc. (ARMP) a New Buy Stock
11/17 01:00 pm
Zacks Investment Research
Read moreArmata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Tops Revenue Estimates
11/10 07:35 pm
Zacks Investment Research
Read moreArmata Pharmaceuticals, Inc. (ARMP) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
11/04 03:01 pm
Zacks Investment Research
Read more